Abbott Laboratories (ABT) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.60% |
| Dec 31, 2025 | -1.53% |
| Sep 30, 2025 | 6.59% |
| Jun 30, 2025 | 25.01% |
| Mar 31, 2025 | 17.43% |
| Dec 31, 2024 | 6.59% |
| Sep 30, 2024 | 9.19% |
| Jun 30, 2024 | 6.71% |
| Mar 31, 2024 | 13.40% |
| Dec 31, 2023 | 8.85% |
| Sep 30, 2023 | 10.60% |
| Jun 30, 2023 | 11.82% |
| Mar 31, 2023 | 19.94% |
| Dec 31, 2022 | 14.91% |
| Sep 30, 2022 | 18.14% |
| Jun 30, 2022 | 43.83% |
| Mar 31, 2022 | 69.60% |
| Dec 31, 2021 | 24.69% |
| Sep 30, 2021 | 23.20% |
| Jun 30, 2021 | 11.27% |
| Mar 31, 2021 | 32.11% |
| Dec 31, 2020 | 24.44% |
| Sep 30, 2020 | 15.96% |
| Jun 30, 2020 | -1.62% |
| Mar 31, 2020 | 4.44% |
| Dec 31, 2019 | 10.87% |
| Sep 30, 2019 | 10.48% |
| Jun 30, 2019 | 12.24% |
| Mar 31, 2019 | 15.15% |
| Dec 31, 2018 | 13.15% |
| Sep 30, 2018 | 16.04% |
| Jun 30, 2018 | 7.06% |
| Mar 31, 2018 | -0.23% |
| Dec 31, 2017 | 97.21% |
| Sep 30, 2017 | 19.92% |
| Jun 30, 2017 | -7.31% |
| Mar 31, 2017 | -19.87% |
| Dec 31, 2016 | 19.00% |
| Sep 30, 2016 | 8.56% |
| Jun 30, 2016 | -14.38% |
| Mar 31, 2016 | -16.63% |
| Dec 31, 2015 | -14.94% |
| Sep 30, 2015 | -9.60% |
| Jun 30, 2015 | -14.61% |
| Mar 31, 2015 | -16.14% |
| Dec 31, 2014 | -14.96% |
| Sep 30, 2014 | -14.99% |
| Jun 30, 2014 | -16.54% |